To evaluate the effect of Qizhiweitong granules on biomarkers in patients with chronic non-atrophic gastritis based on metabolomics

The First Hospital of Hebei Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Aged older than 18 years;
•2. Patients were diagnosed as chronic non-atrophic gastritis (treatment group) by doctors and gastroscopy and pathological examination, otherwise they were considered as healthy subjects (control group);
•3. Have not taken any drugs or health care products in the 14 days before enrollment;
•4. Signing the informed consent.

•1. Menstrual, pregnant and lactating women;
•2. Metabolism related diseases and other digestive diseases;
•3. Subjects who reported other digestive diseases, such as peptic ulcer, panpancreatitis, hepatitis, and cirrhosis of the liver;
•4. Severe heart, brain, liver, kidney or hematopoietic system dysfunction or other serious diseases;
•5. Serious mental illness (such as schizophrenia, depression, anxiety, etc.);
•6. Some factors that affect stomach function, such as diet and lifestyle;
•7. Food or drug allergies;
•8. Unable to return to the doctor on time, lost to follow-up or incomplete data;
•9. Discontinuation of treatment due to adverse reactions.

发起方